Researchers have pushed the depth limits of optical imaging of brain activity by creating an optical platform that is 250-fold more efficient than conventional systems of its kind.
AI isn’t just changing how scientists write up research, but also the way journals publish those papers. Yet collaborative human relationships remain crucial, says Susan King, executive editor at RUP.
Data released from a successful phase 3 trial validate an approach that Rockefeller’s Nathaniel Heintz has pioneered for decades—and could pave the way for a new generation of neurological drugs.
Nathaniel Heintz has spent decades building tools to peer inside individual brain cell types—now he's using those tools to spot some of the earliest changes that occur in neurodegenerative diseases.
Hironori Funabiki studies how the chromosomes carrying our genomic DNA are copied and maintained. His basic research is shedding light on cancer, rare immune diseases, and even how our bodies recognize viruses.
Cysteine is essential for life, but toxic in excess. A new study reveals why: free cysteine can unleash stored iron, overwhelming mitochondria and triggering a form of cell death.
A large clinical trial shows that long-acting antibodies may work with the immune system to control HIV and help reduce the reservoir that would make lifelong treatment necessary.
Grad student Natalie Alexander gravitated to science to feed her wide-ranging curiosity. Now she’s investigating why obesity triggers higher rates of inflammatory skin diseases.
